HuGE Literature Finder
Records
1
-
30
| [The Genetic and Prognostic Characteristics of AML-MRC Patients]. Zhongguo shi yan xue ye xue za zhi 2022 Feb 30 (1): 18-21. Chen Zhe, Mu Qi-Tian, Wu An, Ouyang Gui-Fa |
| Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood 2021 Aug 138 (7): 507-519. Itzykson Raphael, Fournier Elise, Berthon Céline, Röllig Christoph, Braun Thorsten, Marceau-Renaut Alice, Pautas Cécile, Nibourel Olivier, Lemasle Emilie, Micol Jean-Baptiste, Adès Lionel, Lebon Delphine, Malfuson Jean-Valère, Gastaud Lauris, Goursaud Laure, Raffoux Emmanuel, Wattebled Kevin-James, Rousselot Philippe, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, Serve Hubert, Boissel Nicolas, Terré Christine, Celli-Lebras Karine, Preudhomme Claude, Thiede Christian, Dombret Hervé, Gardin Claude, Duployez Nicol |
| [Mutational Spectrum and Prognosis Analysis of AML Patients Based on High-Throughput Sequencing]. Zhongguo shi yan xue ye xue za zhi 2021 Apr 29 (2): 353-362. Li Jian-Xiong, Liu Heng, Sheng Hong-Xia, Zhang B |
| [The Relationship between ASXL2 and ZBTB7A Gene Mutations and Prognosis in Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2021 Apr 29 (2): 450-455. Cao Hui-Qin, Tuo Jin-B |
| Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations. Hematology (Amsterdam, Netherlands) 2021 (1): 340-347. Zhou Lili, An Jingnan, Hou Chang, Ding Zixuan, Qiu Huiying, Tang Xiaowen, Sun Aining, Chen Suning, Xu Yang, Liu Tianhui, Wu Dep |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique. Annals of hematology 2021 Apr . Owattanapanich Weerapat, Herzig Julia, Jahn Nikolaus, Panina Ekaterina, Ruchutrakool Theera, Kungwankiattichai Smith, Issaragrisil Surapol, Döhner Hartmut, Döhner Konstan |
| Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients. Clinical epigenetics 2021 Apr 13 (1): 77. Stomper Julia, Meier Ruth, Ma Tobias, Pfeifer Dietmar, Ihorst Gabriele, Blagitko-Dorfs Nadja, Greve Gabriele, Zimmer Dennis, Platzbecker Uwe, Hagemeijer Anne, Schmitt-Graeff Ingrid, Lübbert Micha |
| Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 2021 (7): 781-789. Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal |
| Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
| Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology. International journal of molecular sciences 2021 Mar 22 (5): . Karantanos Theodoros, Jain Tania, Moliterno Alison R, Jones Richard J, DeZern Amy |
| Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study. Genes, chromosomes & cancer 2021 Jan . Orsmark-Pietras Christina, Landberg Niklas, Lorenz Fryderyk, Uggla Bertil, Höglund Martin, Lehmann Sören, Derolf Åsa, Deneberg Stefan, Antunovic Petar, Cammenga Jörg, Möllgård Lars, Wennström Lovisa, Lilljebjörn Henrik, Rissler Marianne, Fioretos Thoas, Lazarevic Vladimir |
| Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia. American journal of hematology 2021 Jan . Richardson Daniel R, Swoboda David M, Moore Dominic T, Johnson Steven M, Chan Onyee, Galeotti Jonathan, Esparza Sonia, Hussaini Mohammad O, Van Deventer Hendrick, Foster Matthew C, Coombs Catherine C, Montgomery Nathan D, Sallman David A, Zeidner Joshua |
| Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 2021 (1): 111-122. Chen Xiao, Zhu Han, Qiao Chun, Zhao Sishu, Liu Lu, Wang Yan, Jin Huimin, Qian Sixuan, Wu Yuj |
| Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis. Annals of hematology 2021 Jan . Wang Ziqing, Liu Weiyi, Wang Mingjing, Li Yujin, Wang Xueying, Yang Erpeng, Ming Jing, Quan Richeng, Hu Xiaom |
| Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort. Blood advances 2021 Jan 5 (1): 176-184. Chiche Edmond, Rahmé Ramy, Bertoli Sarah, Dumas Pierre-Yves, Micol Jean-Baptiste, Hicheri Yosr, Pasquier Florence, Peterlin Pierre, Chevallier Patrice, Thomas Xavier, Loschi Michael, Genthon Alexis, Legrand Ollivier, Mohty Mohamad, Raffoux Emmanuel, Auberger Patrick, Caulier Alexis, Joris Magalie, Bonmati Caroline, Roth-Guepin Gabrielle, Lejeune Caroline, Pigneux Arnaud, Vey Norbert, Recher Christian, Ades Lionel, Cluzeau Thom |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| [Significance of Targeted Sequencing Assay for Patients with Suspected Myeloid Malignancies]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1985-1990. Zhang Li-Juan, Shi Yu-Ye, Chen Yue, Deng Yuan, Ding Yi-Han, Li Zan, Chen Kan-Kan, Ding Bang-He, Wang Chun-Ling, Yu Liang, He Zheng-M |
| [RUNX1 gene mutations are associated with adverse prognosis of patients with acute myeloidleukemia]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2020 Nov 40 (11): 1601-1606. Yang Yanli, Li Tiantian, Geng Yinghua, Li J |
| Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy. International journal of laboratory hematology 2020 Jul . Ni Jing, Hong Jian, Long Zhangbiao, Li Qingsheng, Xia Ruixiang, Zeng Qings |
| Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia. American journal of hematology 2020 Jul . Aldoss Ibrahim, Zhang Jianying, Mei Matthew, Al Malki Monzr M, Arslan Shukaib, Ngo Dat, Aribi Ahmed, Ali Haris, Sandhu Karamjeet, Salhotra Amandeep, Koller Paul, Khaled Samer, Artz Andrew, Snyder David, Nakamura Ryotaro, Forman Stephen J, Stein Anthony A, Marcucci Guido, Pullarkat Vin |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype. Cancer medicine 2020 Mar . Prats-Martín Concepción, Burillo-Sanz Sergio, Morales-Camacho Rosario M, Pérez-López Olga, Suito Milagros, Vargas Maria T, Caballero-Velázquez Teresa, Carrillo-Cruz Estrella, González José, Bernal Ricardo, Pérez-Simón José |
| [Analysis of ASXL1 gene variant in patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Feb 37 (2): 110-115. Chen Meiyu, Liu Jie, Chao Hongying, Qin Wei, Jiang Naike, Lu Xuzhang, Cen Ling, Jiang Yu, Cai Xiaohui, Zhang Ri, Wang Qi |
| [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Feb 28 (1): 202-208. Cai Xiao-Hui, Chen Mei-Yu, Chao Hong-Ying, Jiang Nai-Ke, Lu Xu-Zhang, Han Wen-Min, Qin Wei, Jia Zhu-X |
| [NRAS Gene Expression and Its Clinical Significance in Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2020 Feb 28 (1): 76-81. Li Tian-Tian, Li Jun, Geng Ying-Hua, Zhang Feng, Liu Lin, Yang Yan- |
| A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood advances 2020 Feb 4 (4): 644-654. Wang Yu-Hung, Lin Chien-Chin, Yao Chi-Yuan, Hsu Chia-Lang, Hou Hsin-An, Tsai Cheng-Hong, Chou Wen-Chien, Tien Hwei-Fa |
| Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1. Leukemia & lymphoma 2020 Feb 1-11. Nguyen Lynh, Zhang Xiaohui, Roberts Evans, Yun Seongseok, McGraw Kathy, Abraham Ivo, Song Jinming, Braswell Diana, Qin Dahui, Sallman David A, Lancet Jeffrey E, List Alan F, Moscinski Lynn C, Padron Eric, Zhang Li |
| Defining Acute Myeloid Leukemia Ontogeny in Older Patients. Clinical lymphoma, myeloma & leukemia 2019 Nov . Melody Megan, Kuykendall Andrew, Sallman David, Al Ali Najla, Zhang Ling, Talati Chetasi, Padron Eric, Sweet Kendra, Extermann Martine, List Alan, Lancet Jeffrey, Komrokji Ra |
| Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia. Cancer 2019 Nov . Sasaki Koji, Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Assi Rita, Jabbour Elias, Ravandi Farhad, Kadia Tapan, Pierce Sherry, Takahashi Koichi, Nogueras Gonzalez Graciela, Patel Keyur, Soltysiak Kelly A, Cortes Jorge, Kantarjian Hagop, Garcia-Manero Guiller |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 18, 2022
- Content source: